Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 755-758

  Baldridge, Jory R ^a,b   McGraw, Tanya S ^a   Paoletti, Alyssa ^a   Buchmeier, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; INFECTION RESISTANCE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; PASSIVE IMMUNIZATION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE;

EID: 0031060501     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.755-758.1997     Document Type: Article

References (23)

1. Ahmed, R., C. S. Hahn, T. Somasundaram, L. Villarete, M. Matloubian, and J. H. Strauss. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:4242-4247.
2. Ahmed, R., A. Salmi, L. Butler, J. Chiller, and M. B. A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
3. Baldridge, J., and M. J. Buchmeier. 1992. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66:4252-4257.
4. Baldridge, J., B. Pearce, B. Parekh, and M. J. Buchmeier. 1993. Teratogenic effects of neonatal arenavirus infection on the developing rat cerebellum are abrogated by passive immunotherapy. Virology 197:669-677.
5. Borrow, P., C. F. Evans, and M. B. A. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059-1070.
6. Borrow, P., A. Tishon, and M. B. A. Oldstone. 1991. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. J. Exp. Med. 174:203-212.
7. Buchmeier, M., R. Welsh, F. Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331.
8. Doherty, P., S. Hou, and P. Southern. 1993. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J. Neuroimmunol. 46:11-18.
9. Haywood, A. 1986. Patterns of persistent viral infections. N. Engl. J. Med. 315:939-948.
10. Hollinger, F. 1990. Hepatitis B virus, p. 2171-2236. In B. N. Fields and D. Knipe (ed.), Virology, 2nd ed., Raven Press, New York, N.Y.
11. Hotchin, J. 1962. The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27: 479-499.
12. King, C. C., R. de Fries, S. R. Kolhekar, and R. Ahmed. 1990. In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J. Virol. 64:5611-5616.
13. Koller, B., P. Marrack, J. Kappler, and O. Smithies. 1990. Normal development of mice deficient in b2M, MHC class I proteins and CD8 + T cells. Science 248:1227-1230.
14. 2-microglobulin gene. J. Virol. 67:332-339.
15. Matloubian, M., S. R. Kolhekar, T. Somasundaram, and R. Ahmed. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:7340-7349.
16. + cytotoxic T-eell responses during chronic viral infection. J. Virol. 68:8056-8063.
17. Oldstone, M. B. A., P. Blount, P. J. Southern, and P. J. Lampert. 1986. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 321:239-243.
18. Oldstone, M. B. A., and F. Dixon. 1972. Disease accompanying in utero viral infection. The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus. J. Exp. Med. 135:827-838.
19. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. de la Torre, T. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372-4378.
20. Prober, C., and A. Arvin. 1987. Perinatal viral infections. Eur. J. Clin. Microbiol. 6:245-261.
21. Scarlatti, G., J. Albert, P. Rossi, V. Hodara, P. Biraghi, L. Mugglasca, and E. Fenyo. 1993. Mother-to child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates J. Infect. Dis. 168:207-210.
22. Wright, K. E., and M. J. Buchmeier. 1991. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J. Virol. 65:3001-3006.
23. Wright, K. E., M. Salvato, and M. J. Buchmeier. 1989. Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology 171:417-426.